Phys Vivas · dermatological
Pyoderma Gangrenosum AND Neutrophilic Dermatoses — Viva Defence
DCE viva defence for Pyoderma Gangrenosum AND Neutrophilic Dermatoses.
On this page
Study tools
Target exams
Pyoderma Gangrenosum AND Neutrophilic Dermatoses Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Pyoderma Gangrenosum AND Neutrophilic Dermatoses. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References3ShowHide
- [1]Maverakis E, Ma C, Shinkai K, Fiorentino D, et al. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts JAMA Dermatol, 2018.PMID 29450466
- [2]Yamamoto T, Yamasaki K, Yamanaka K, Komine M, et al. Clinical guidance of pyoderma gangrenosum 2022 J Dermatol, 2023.PMID 37311717
- [3]Jockenhöfer F, Wollina U, Salva KA et al. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum The British journal of dermatology, 2019.PMID 29388188